mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |